ADUS vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?
Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
JMP Securities initiated coverage on Addus HomeCare Corp ADUS, a provider of home-based personal care and clinical services.
Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADUS vs. ASTH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now?
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript
Addus HomeCare Corporation (NASDAQ:ADUS ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Tao Qiu - Macquarie Scott Fidel - Stephens Jared Haase - William Blair Matthew Gillmor - KeyBanc Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good day, and welcome to the Addus HomeCare's Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Addus HomeCare (ADUS) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Addus HomeCare (ADUS) Q3 Earnings and Revenues Surpass Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.15 per share a year ago.
Addus HomeCare (ADUS) Reports Next Week: Wall Street Expects Earnings Growth
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks to Buy in an Evolving Outpatient Home Health Industry
Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised to gain.
